Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 3,579 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Pain, Osteoarthritis, Knee
Interventions: Transdermal Ketoprofen Patch with CHADD, Placebo transdermal patch; Drug
Lead sponsor: ZARS Pharma Inc.; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 5
States / cities: Buena Park, California • Washington D.C., District of Columbia • Daytona Beach, Florida + 2 more

Conditions: Coronary Arteries Disease
Interventions: PRO-Kinetic Energy Stent; Device
Lead sponsor: Biotronik, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 329 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 28
States / cities: Phoenix, Arizona • Concord, California • Mission Viejo, California + 24 more

Conditions: Tobacco Use Disorder
Interventions: nicotine transdermal system, bupropion, Medication Management, Mayo Counseling, placebo patch, placebo bupropion; Drug · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 75 Years
Enrollment: 260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiac Arrhythmia
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Age-Related Memory Disorders
Interventions: Transdermal nicotine patch, Placebo transdermal patch; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 55 Years to 90 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Durham, North Carolina • Burlington, Vermont

Conditions: Benign Pigmented Lesions
Interventions: LaseMD and DUAL 1927nm Laser, LaseMD; Device
Lead sponsor: CynosureLutronic; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Hunt Valley, Maryland • Charlotte, North Carolina

Conditions: Peripheral Pulmonary Lesion, Lung Nodule, Solitary
Interventions: Robotic assisted bronchoscopy (RAB), Electromagnetic navigation bronchoscopy (ENB); Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 4
States / cities: Chicago, Illinois • Baltimore, Maryland • Nashville, Tennessee

Conditions: Basal Cell Carcinoma
Interventions: 1064 nm long-pulse Nd:YAG laser; Device
Lead sponsor: Sciton; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Spring Hill, Tennessee

Conditions: Vascular; Lesion, Central Nervous System, Brain Tumor, Cerebral Aneurysm, Cerebral AVM
Interventions: GLOW800, indocyanine green (ICG); Device · Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Liver Cancer
Interventions: Ad5CMV-p53 gene; Biological
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1998
U.S. locations: 2
States / cities: The Bronx, New York • Pittsburgh, Pennsylvania

Conditions: Pain Associated With Epidural Needle Insertion
Interventions: Synera(TM), Placebo patch; Drug · Other
Lead sponsor: IWK Health Centre; Other
Eligibility: 18 Years and older · Female only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Alopecia Areata
Interventions: Targretin Gel 1%; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Colorectal Cancer; Lung Cancer
Interventions: TATE and pembrolizumab, TAS-102 pill, Regorafenib Pill; Drug
Lead sponsor: Teclison Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Orange, California

Conditions: Atrial Fibrillation, Postoperative
Interventions: The intervention includes Amiodarone-Infused CardiaMend patches (70mg, 150mg and 300mg); Combination Product
Lead sponsor: Helios Cardio Inc.; Industry
Eligibility: 20 Years to 85 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Squamous Cell Carcinoma
Interventions: Induction radiotherapy, Vilastobart, Opdualag; Radiation · Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Lung Cancer, Pulmonary Nodule
Interventions: Ion Endoluminal System; Device
Lead sponsor: Intuitive Surgical; Industry
Eligibility: 18 Years and older
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Winchester, Virginia

Conditions: Healthy Population, Chronic Disease
Interventions: Verily Clinical Study Watch, Vivalink ECG Patch, Modus StepWatch 4; Device
Lead sponsor: Verily Life Sciences LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: South San Francisco, California

Conditions: Low Back Pain
Interventions: Buprenorphine transdermal system, Placebo; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 18 Years and older
Enrollment: 539 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 86
States / cities: Anniston, Alabama • Mobile, Alabama • Chandler, Arizona + 71 more

Conditions: Brain and Central Nervous System Tumors, Metastatic Cancer, Radiation Toxicity
Interventions: Questionnaire; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Lung Cancer
Interventions: CT Scan, Lung CT, MRI, Walk Test, SGRQ, Biological Sample Collection, Toxicity, Cardiac Assessment; Other
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Central Nervous System Disease, Cerebrovascular Accident, Stroke
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Osteoarthritis
Interventions: Buprenorphine transdermal patch; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 40 Years and older
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 66
States / cities: Birmingham, Alabama • Huntsville, Alabama • Montgomery, Alabama + 55 more

Conditions: Psoriasis
Interventions: MOL4239, Placebo; Drug
Lead sponsor: Moleculin, LLC; Industry
Eligibility: 18 Years to 72 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 3
States / cities: Miami, Florida • Fridley, Minnesota • Albuquerque, New Mexico

Conditions: Non-palpable Breast Lesions
Interventions: RFID Tag (Health Beacon); Device
Lead sponsor: Health Beacons; Industry
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 3
States / cities: San Diego, California • Torrance, California • Denver, Colorado

Search by objective public record fields.

Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee

BIOHELIX-I Bare Metal Stent Study

Comparing Smoking Treatment Programs for Lighter Smokers - 1

Patient Status Engine (PSE): EARLY FEASIBILITY AND USABILITY STUDY

Nicotine Treatment of Mild Cognitive Impairment (MCI)

Lutronic LaseMD for Treatment of Benign Pigmented Lesions

Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT Using Integrated Intraprocedural Imaging

Laser Treatment of Basal Cell Carcinoma

Intraoperative Fluorescence With Augmented Reality

Gene Therapy in Treating Patients With Cancer of The Liver

Synera™ for Epidural Needle Insertion

Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects

Triplet Immunotherapy For Exhausted Cell Targets in Advanced Squamous Cell Carcinoma

A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions

Verily Clinical Study Watch Analytical Validation Study

Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Functional Imaging in Lung SBRT

Influence of Area of Brain Damage on Brain Reorganization After Chronic Stroke

Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.

Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis

Evaluation of RFID Localization System for Marking and Retrieving Breast Lesions